<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CAT</journal-id>
<journal-id journal-id-type="hwp">spcat</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Appl Thromb Hemost</journal-id>
<journal-title>Clinical and Applied Thrombosis/Hemostasis</journal-title>
<issn pub-type="ppub">1076-0296</issn>
<issn pub-type="epub">1938-2723</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1076029612448420</article-id>
<article-id pub-id-type="publisher-id">10.1177_1076029612448420</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Comment About the Correct Attribution of the Discovery of FX Friuli Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Girolami</surname>
<given-names>Antonio</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1076029612448420">1</xref>
<xref ref-type="corresp" rid="corresp1-1076029612448420"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonamigo</surname>
<given-names>Emanuela</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1076029612448420">1</xref>
</contrib>
<aff id="aff1-1076029612448420">
<label>1</label>Department of Medicine, University of Padua Medical School, Via Ospedale, 105, Padua, Italy</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1076029612448420">Antonio Girolami, Department of Medicine, University of Padua Medical School, Via Ospedale, 105, Padua, Italy Email: <email>antonio.girolami@unipd.it</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>6</issue>
<fpage>668</fpage>
<lpage>669</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>We have read with some interest and surprise the article by Barillari et al<sup>
<xref ref-type="bibr" rid="bibr1-1076029612448420">1</xref>
</sup> on the use of prothrombin complex concentrates (PCCs) in a patient with FX Friuli disorder.</p>
<p>Such article contains a few scientific, historical, and deontological inaccuracies which should be corrected lest wrong data be circulated much to the confusion of the readers.</p>
<p>The FX Friuli variant was not discovered by Fair et al as stated by the authors in page 334, at the beginning of second column.<sup>
<xref ref-type="bibr" rid="bibr1-1076029612448420">1</xref>
</sup> The article by Dr Fair, Revak, Hubbard, and Girolami of 1989 (quoted by the authors as ref 16) dealt only with the isolation and characterization of the FX Friuli abnormal protein.<sup>
<xref ref-type="bibr" rid="bibr2-1076029612448420">2</xref>
</sup> The discovery of the mutation underlying the FX Friuli defect was reported in a 1991 article by James working in collaboration with the Padua group.<sup>3</sup>
</p>
<p>The defect had been originally recognized and described in Padua in 1970 and 1971 in a series of articles, which firmly established the clinical features and the peculiar laboratory pattern (low activity in the extrinsic and intrinsic systems, normal activity in the Russell viper venom assay, normal antigen) of the condition.<sup>
<xref ref-type="bibr" rid="bibr4-1076029612448420">4</xref>
<xref ref-type="bibr" rid="bibr5-1076029612448420"/>–<xref ref-type="bibr" rid="bibr6-1076029612448420">6</xref>
</sup>
</p>
<p>We cannot abstain from noting that it would have been scientifically correct to acknowledge this by quoting the original articles. Incidentally the patient presented by the authors belongs to the large kindred studied by us in 1970 and reported in one of the original articles (patient IVa of Figure1).<sup>
<xref ref-type="bibr" rid="bibr4-1076029612448420">4</xref>
</sup> Basic deontological principles would have required such acknowledgment.</p>
<p>Furthermore, the authors could have obtained useful comparative information on the use of PCC in these patients by quoting another article of ours,<sup>
<xref ref-type="bibr" rid="bibr7-1076029612448420">7</xref>
</sup> where they could have found useful information on survival times of administered FX. The citation of this article could have been surely more pertinent than some of the articles listed in the references. One could wonder, for example, why the authors quoted 3 articles<sup>
<xref ref-type="bibr" rid="bibr1-1076029612448420">1</xref>
</sup>
<sup>,<xref ref-type="bibr" rid="bibr2-1076029612448420">2</xref>,<xref ref-type="bibr" rid="bibr7-1076029612448420">7</xref>
</sup> which have the same title and an almost identical content.</p>
<p>Finally, the patient is reported to have less than 1% FX clotting activity. This is surprising and probably untenable since all homozygous patients with homozygous FX Friuli defect have always shown levels of about of 3% to 6% of normal in the intrinsic and/or extrinsic systems. A level so low suggests the concomitant presence of inhibitors, liver damage, or amyloidosis. </p>
<p>This reported very low value is also in contradiction with what was stated by the authors in the discussion, namely that the FX activity in these patients is not very low (page 334, second column).</p>
<p>To avoid further wrong statements and to clarify fully the story of factor X Friuli, we thought it useful to summarize the events in the <xref ref-type="table" rid="table1-1076029612448420">Table 1</xref>.</p>
<table-wrap id="table1-1076029612448420" position="float">
<label>Table 1</label>
<caption>
<p>The Long Story of FX Friuli Disorder</p>
</caption>
<graphic alternate-form-of="table1-1076029612448420" xlink:href="10.1177_1076029612448420-table1.tif"/>
<table>
<thead>
<tr>
<th>Authors (Ref)</th>
<th>Year</th>
<th>Diagnostic Conclusion</th>
<th>Comments</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chevallier et al<sup>
<xref ref-type="bibr" rid="bibr8-1076029612448420">8</xref>
</sup>
</td>
<td>1955</td>
<td>Factor VII deficiency </td>
<td>Study on 2 patients living in France</td>
</tr>
<tr>
<td>Chevallier et al<sup>
<xref ref-type="bibr" rid="bibr9-1076029612448420">9</xref>
</sup>
</td>
<td>1959</td>
<td>Classical factor X deficiency</td>
<td>Study on same 2 patients living in France</td>
</tr>
<tr>
<td>Venturelli et al<sup>
<xref ref-type="bibr" rid="bibr10-1076029612448420">10</xref>
</sup>
</td>
<td>1961</td>
<td>Prothrombin complex defect</td>
<td>Study on 1 patient</td>
</tr>
<tr>
<td>Girolami et al<sup>
<xref ref-type="bibr" rid="bibr3-1076029612448420">3</xref>
</sup>
<sup>-<xref ref-type="bibr" rid="bibr5-1076029612448420">5</xref>
</sup>
</td>
<td>1970-1971</td>
<td>Abnormal FX (FX Friuli) disorder</td>
<td>Study on 7 homozygotes and 80 heterozygotes</td>
</tr>
<tr>
<td>Fair et al<sup>
<xref ref-type="bibr" rid="bibr2-1076029612448420">2</xref>
</sup>
</td>
<td>1989</td>
<td>Isolation and characterization of abnormal FX Friuli protein</td>
<td>Study on 2 patients supplied by Padua group</td>
</tr>
<tr>
<td>James et al<sup>
<xref ref-type="bibr" rid="bibr7-1076029612448420">7</xref>
</sup>
</td>
<td>1991</td>
<td>Underlying mutation established</td>
<td>Study on 3 patients supplied by Padua group</td>
</tr>
<tr>
<td>Kim et al<sup>
<xref ref-type="bibr" rid="bibr11-1076029612448420">11</xref>
</sup>
</td>
<td>1996</td>
<td>Expression studies confirming relevance of mutation</td>
<td>In collaboration with Padua group</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>This gives an idea of the complexity and the difficulties encountered in the diagnosis of this peculiar defect and will be of interest to the readers. Many attempts were made through the years by several authors<sup>
<xref ref-type="bibr" rid="bibr8-1076029612448420">8</xref>
<xref ref-type="bibr" rid="bibr9-1076029612448420"/>–<xref ref-type="bibr" rid="bibr10-1076029612448420">10</xref>
</sup> but the right diagnosis was reached by the Padua group in 1970.<sup>
<xref ref-type="bibr" rid="bibr4-1076029612448420">4</xref>,<xref ref-type="bibr" rid="bibr5-1076029612448420">5</xref>
</sup> Molecular biology confirmation of the correctness of the diagnosis was reached later in collaboration with the Department of Biochemistry of the Texas University at Tyler.<sup>
<xref ref-type="bibr" rid="bibr7-1076029612448420">7</xref>,<xref ref-type="bibr" rid="bibr11-1076029612448420">11</xref>
</sup>
</p>
<p>We do hope the authors will show in the future a more appropriate approach to the subject and a due respect to the work of those who originally studied the disorders and, more importantly, to the truth.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-1076029612448420">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barillari</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pasca</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gonano</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Daminato</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Prothrombin complex concentrate such as therapy and prophylaxis in factor X-deficient patient (Friuli variant)</article-title>. <source>Clin Appl Thromb Hemost</source>. <year>2011</year>;<volume>17</volume>(<issue>4</issue>):<fpage>332</fpage>–<lpage>336</lpage>.</citation>
</ref>
<ref id="bibr2-1076029612448420">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fair</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Revak</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Hubbard</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Girolami</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Isolation and characterization of the factor X Friuli variant</article-title>. <source>Blood</source>. <year>1989</year>;<volume>73</volume>(<issue>8</issue>):<fpage>2108</fpage>–<lpage>2116</lpage>.</citation>
</ref>
<ref id="bibr7-1076029612448420">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Girolami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fair</surname>
<given-names>DS</given-names>
</name>
</person-group>. <article-title>Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343</article-title>. <source>Blood</source>. <year>1991</year>;<volume>77</volume>(<issue>2</issue>):<fpage>317</fpage>–<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr3-1076029612448420">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girolami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Molaro</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lazzarin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scarpa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brunetti</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>Congenital haemorrhagic condition similar but not identical to factor X deficiency. A haemorrhagic state due to an abnormal factor X?</article-title> <source>Scand J Haematol</source>. <year>1970</year>;<volume>7</volume>:<fpage>91</fpage>–<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr4-1076029612448420">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girolami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Molaro</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lazzarin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scarpa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brunetti</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>A “new” congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred</article-title>. <source>Br J Haematol</source>. <year>1970</year>;<volume>19</volume>(<issue>2</issue>):<fpage>179</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr5-1076029612448420">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girolami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lazzarin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scarpa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brunetti</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Further studies on the abnormal factor X (factor X Friuli) coagulation disorder: a report of another family</article-title>. <source>Blood</source>. <year>1971</year>;<volume>37</volume>(<issue>5</issue>):<fpage>534</fpage>–<lpage>541</lpage>.</citation>
</ref>
<ref id="bibr6-1076029612448420">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girolami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Molaro</surname>
<given-names>G</given-names>
</name>
<name>
<surname>De Marco</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Factor X survival and therapeutic factor X levels in the abnormal factor X (factor X Friuli) coagulation disorder</article-title>. <source>Acta Haematol</source>. <year>1974</year>;<volume>52</volume>(<issue>4</issue>):<fpage>223</fpage>–<lpage>231</lpage>. </citation>
</ref>
<ref id="bibr8-1076029612448420">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chevallier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fieherer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bilski-Pasquier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Samama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cerf</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Deux cas d’hypoproconvertinemie familiale</article-title>. <source>Sang</source>. <year>1955</year>;<volume>25</volume>(<issue>7</issue>):<fpage>650</fpage>–<lpage>655</lpage>.</citation>
</ref>
<ref id="bibr9-1076029612448420">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chevallier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bilski-Pasquier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>De Grouchy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Samama</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Déficience congénital et familiale en facteur Stuart</article-title>. <source>Sang</source>. <year>1959</year>;<volume>30</volume>(<issue>5</issue>):<fpage>525</fpage>–<lpage>530</lpage>.</citation>
</ref>
<ref id="bibr10-1076029612448420">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venturelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Molaro</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Camoretto</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Intervento chirurgico in soggetto affetto da deficit congenito del complesso protrombinico</article-title>. <source>Trasf Sangue</source>. <year>1961</year>;<volume>6</volume>(<issue>3</issue>):<fpage>34</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr11-1076029612448420">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Girolami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>James</surname>
<given-names>HL</given-names>
</name>
</person-group>. <article-title>Characterization of recombinant human coagulation factor XFriuli</article-title>. <source>Thromb Haemost</source>. <year>1996</year>;<volume>75</volume>:<fpage>313</fpage>–<lpage>317</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>